KNW logo

Know Labs (KNW) Stock

Profile

Sector:

Technology

Country:

United States

IPO:

18 April 2006

Indexes:

Not included

Description:

Know Labs (KNW) focuses on developing innovative technology for health monitoring. Their main product is a non-invasive glucose monitoring device that helps people manage diabetes. By using advanced sensors, they aim to provide accurate health data, improving the quality of life for users.

Events Calendar

Earnings

Next earnings date:

Feb 14, 2025

Recent quarterly earnings:

Nov 15, 2024

Recent annual earnings:

Nov 15, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

June 17, 2015

Analyst ratings

Recent major analysts updates

29 May '24 Benchmark
Speculative Buy
08 Apr '24 Benchmark
Speculative Buy
08 Feb '22 Dawson James
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Know Labs, Inc. Announces Receipt of Audit Opinion with Going Concern Explanation
Know Labs, Inc. Announces Receipt of Audit Opinion with Going Concern Explanation
Know Labs, Inc. Announces Receipt of Audit Opinion with Going Concern Explanation
KNW
businesswire.com15 November 2024

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), leading developer of non-invasive diagnostics technology, today announced that, as previously disclosed in its Annual Report on Form 10-K for the year ended September 30, 2024, which was filed on November 14, 2024 with the Securities and Exchange Commission, the audited financial statements contained an audit opinion from its independent registered public accounting firm that included an explanatory paragraph related to the Company.

Know Labs Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
Know Labs Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
Know Labs Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
KNW
businesswire.com02 October 2024

SEATTLE--(BUSINESS WIRE)--Know Labs Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards. A Plan for Compliance has been undertaken.

Know Labs, Inc. (KNW) Q3 2024 Earnings Call Transcript
Know Labs, Inc. (KNW) Q3 2024 Earnings Call Transcript
Know Labs, Inc. (KNW) Q3 2024 Earnings Call Transcript
KNW
seekingalpha.com14 August 2024

Know Labs, Inc. (NYSE:KNW ) Q3 2024 Results Earnings Conference Call August 14, 2024 4:30 PM ET Company Participants Ron Erickson - Chairman and Chief Executive Officer Peter Conley - Chief Financial Officer and Senior Vice President, IP Conference Call Participants Operator Greetings. Welcome to Know Labs's Third Quarter 2024 Earnings Conference Call.

Know Labs, Inc. Announces Closing of $3.445 Million Public Offering
Know Labs, Inc. Announces Closing of $3.445 Million Public Offering
Know Labs, Inc. Announces Closing of $3.445 Million Public Offering
KNW
businesswire.com12 August 2024

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostics technology, today announced the successful closing of its previously announced underwritten public offering of 13,250,000 units at a public offering price of $0.26 per unit, with each unit consisting of one share of its common stock and one warrant to purchase one share of its common stock at an initial exercise price of $0.26, and the partial exercise of the underwriters' opt.

Know Labs, Inc. (KNW) Q3 2023 Earnings Call Transcript
Know Labs, Inc. (KNW) Q3 2023 Earnings Call Transcript
Know Labs, Inc. (KNW) Q3 2023 Earnings Call Transcript
KNW
Seeking Alpha17 August 2023

Know Labs, Inc. (NYSE:KNW ) Q3 2023 Results Conference Call August 14, 2023 4:30 PM ET Company Participants Jordyn Hujar - Chief of Staff Ron Erickson - Chairman and Chief Executive Officer Pete Conley - Senior Vice President and Chief Financial Officer Operator Greetings. Welcome to the Know Labs Fiscal Year 2023 Third Quarter Earnings Conference Call.

FAQ

  • What is the primary business of Know Labs?
  • What is the ticker symbol for Know Labs?
  • Does Know Labs pay dividends?
  • What sector is Know Labs in?
  • What industry is Know Labs in?
  • What country is Know Labs based in?
  • When did Know Labs go public?
  • Is Know Labs in the S&P 500?
  • Is Know Labs in the NASDAQ 100?
  • Is Know Labs in the Dow Jones?
  • When was Know Labs's last earnings report?
  • When does Know Labs report earnings?
  • Should I buy Know Labs stock now?

What is the primary business of Know Labs?

Know Labs (KNW) focuses on developing innovative technology for health monitoring. Their main product is a non-invasive glucose monitoring device that helps people manage diabetes. By using advanced sensors, they aim to provide accurate health data, improving the quality of life for users.

What is the ticker symbol for Know Labs?

The ticker symbol for Know Labs is NYSE:KNW

Does Know Labs pay dividends?

No, Know Labs does not pay dividends

What sector is Know Labs in?

Know Labs is in the Technology sector

What industry is Know Labs in?

Know Labs is in the Scientific & Technical Instruments industry

What country is Know Labs based in?

Know Labs is headquartered in United States

When did Know Labs go public?

Know Labs's initial public offering (IPO) was on 18 April 2006

Is Know Labs in the S&P 500?

No, Know Labs is not included in the S&P 500 index

Is Know Labs in the NASDAQ 100?

No, Know Labs is not included in the NASDAQ 100 index

Is Know Labs in the Dow Jones?

No, Know Labs is not included in the Dow Jones index

When was Know Labs's last earnings report?

Know Labs's most recent earnings report was on 15 November 2024

When does Know Labs report earnings?

The next expected earnings date for Know Labs is 14 February 2025

Should I buy Know Labs stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions